TRIP is a CBD brand that sells wellness products infused with adaptogens.
TRIP has raised $40.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
TRIP's investors include Alessandra Ambrosio, Coefficient Capital, Christian Angermayer, Maria Raga, Joe Jonas.
TRIP is headquartered in London, United Kingdom.
TRIP is a CBD brand that sells wellness products infused with adaptogens.
TRIP is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TRIP — Funding & Investors." VCBacked, November 10, 2025, https://www.vcbacked.co/company/trip. Accessed September 2, 2026.
VCBacked. (2025). TRIP — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/trip
{{cite web |title=TRIP — Funding & Investors |url=https://www.vcbacked.co/company/trip |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated